|
FREE patent keyword monitoring and additional FREE benefits. |
|
|
Drug, Bio-affecting And Body Treating Compositions > Plant Material Or Plant Extract Of Undetermined Constitution As Active Ingredient (e.g., Herbal Remedy, Herbal Extract, Powder, Oil, Etc.) > Containing Or Obtained From A Tree Having Matured Height Of At Least Two Meters Containing Or Obtained From A Tree Having Matured Height Of At Least Two MetersContaining Or Obtained From A Tree Having Matured Height Of At Least Two Meters patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/02/07 - 20070178180 - Process for producing a therapeutically effective amount of an extract from pomegranate and compositions relating to same Methods of using pomegranate extracts of the present invention for treating patients with atherosclerosis, or increased intima-media thickness of an artery, are provided. The methods comprise the step of administering to the patient a composition comprising a therapeutically effective amount of an extract from pomegranate. The methods of the present ... 08/02/07 - 20070178179 - Pharmaceutical composition for treatment of diabetes and dyslipidemia A bioactive fraction obtained from Xylocarpus that is useful for the treatment of diabetes and dyslipidemia. This fraction can be provided in a pharmaceutical composition that is useful as antidiabetic and antidyslipidemic agent, or can be used in a method of treating diabetes and dyslipidemia in a subject. Also, a ... 07/19/07 - 20070166415 - Safe medicine for treating and preventing cancer and method of use The present invention provides a new method for extracting Homoharringtonine (HHT) by culture cells or culture plant tissues. Also, disclosed are methods of obtaining HHT from semi-synthesis and biosynthesis. The present invention disclosed that HHT combined with some botanical drugs could induce cancer cells to resemble normal cells. To add ... 07/12/07 - 20070160699 - Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof Hovenia dulcis Thunb extract, Lindera obtusiloba extract or herbal mixture extract thereof of the present invention promotes cell viability in liver and kidney cell lines, indicating that the extract has excellent liver and kidney cell protective effects. Therefore, the composition of the present invention can be effectively used not only ... 06/21/07 - 20070141187 - Compositions for protection against superficial vasodilator flush syndrome, and methods of use Compositions for protection against SVFS syndromes are composed of a flavonoid compound of the basic structures 2-phenyl-4H-1-benzopyran or 2-phenyl-4-keto-1-benzopyran or glycosides thereof, an inventive olive kernel extract and a non-bovine sulfated proteoglycan, and, optionally, one or more of bitter willow extract, D-glucosamine sulfate and serotonin inhibitor. ... 05/31/07 - 20070122507 - Histone deacetylase and tumor necrosis factor converting enzyme inhibition The present invention relates to methods and compositions for inhibiting Histone Deacetylase (“HDAC”) and/or Tumor Necrosis Factor Converting Enzyme (“TACE”) in living organisms. More particularly, the present invention relates to methods and compositions involving the inhibition of HDAC and/or TACE using processed Morinda citrifolia L. plant products. ... 05/31/07 - 20070122506 - Process for the isolation of oleane compounds isolated from the bark of arjun tree terminalia arjuna (roxb.) The present invention provides an improved process for the isolation of oleane compounds from the bark of Terminallia arjuna (Roxb.). More particularly, the present invention relates to an improved process for the isolation of arjunic acid and its derivates from the bark of Terminallia arjuna (Roxb.). The present invention further ... 04/19/07 - 20070087066 - Antifungal effects of morinda citrifolia The present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ... 04/05/07 - 20070077317 - Olive kernel composition containing absorption promoters, antioxidants, and anti-inflammatory agents The claimed invention is composition comprising an organic extract of de-fleshed, purified, isolated olive kernels that contains one or more components that increase absorption of macromolecules such as proteoglycans across cell membranes, that have antioxidant properties, and that have anti-inflammatory effects in tissues. ... 02/08/07 - 20070031522 - Enriched aqueous components of emblica officinalis In an extraction process comprising extracting a raw extract from Emblica officinalis the improvement comprising conducting the extraction under conditions of time, temperature and atmosphere, to inhibit the formation of black specks and/or oligomeric and/or polymeric tannins and/or oxidation products thereof. ... 01/25/07 - 20070020350 - Vegetation water composition for treatment of inflammatory skin conditions Compositions obtained from vegetation water from olives and methods for treating patients suffering from an inflammatory skin disease with the compositions are described. Included are hydroxytyrosol rich compounds obtained from olive vegetation water. ... 01/11/07 - 20070009620 - Cholesterol regulating agent It is an object of the present invention to provide a HDL cholesterol-raising agent which can selectively raise or maintain HDL cholesterol level, an LDL cholesterol-lowering agent which can selectively lower LDL cholesterol level, a composition which can selectively raise of maintain HDL cholesterol level, a method for raising or ... 01/04/07 - 20070003645 - Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity or pain The present invention relates to a composition comprising an extract or a concentrate of Butyrospermum parkii as a dietary supplement or a pharmaceutical composition and to the use of such compositions for the preparation of a medicament or a dietary supplement for the suppression of hypersensitivity and/or inflammatory reaction. The ... 12/28/06 - 20060292255 - Pharmaceutical and therapeutic compositions derived from garcinia mangostana l plant The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a ... 12/14/06 - 20060280819 - Ellagic acid food supplement prepared from pomegranate seed A food supplement material, and method of its preparation, containing ellagic acid (i.e., in the form of bio-available ellagitannins) and also containing the so-called punicosides (i.e., punicalagins A and B), is derived from pomegranate plant materials. Most preferably, the food supplement is extracted from pomegranate seed (although the whole fruit ... 12/14/06 - 20060280818 - Nicotinic acetylcholine receptor antagonist The present invention relates to methods and compositions which act as nicotinic acetylcholine receptor antagonist in living organisms. More particularly, the present invention relates to methods and compositions which act as nicotinic acetylcholine receptor antagonist using processed Morinda citrifolia L. plant products. ... 12/07/06 - 20060275518 - Method for treating infectious diseases A pharmaceutical formulation for oral administration containing root, bark and wood of Philippine Narra tree (Pterocarpus Indicus) in dried powder form in sachet in a unit of 2 to 3 grams and made into a decoction of 8 ounces or in capsule in a unit of 100 to 300 milligrams ... 11/30/06 - 20060269631 - Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells The present invention features processed ingredients from the Indian mulberry plant, and particularly Morinda citrifolia fruit juice, for inhibiting and preventing metastasis of carcinogenic cells, as well as destroying metastasized cells. At least some implementations of the present invention comprise the consumption of food products or medicinal products or compositions ... 11/30/06 - 20060269630 - Morinda citrifolia as a 5-lipoxygenase inhibitor The present invention is directed to methods and formulations for inhibiting Lipoxygenase or Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing inflammatory diseases and the symptoms associated with such diseases. The present ... 11/30/06 - 20060269629 - Processes for extracting phytochemicals from pomegranate solids and compositions and methods of use thereof Processes for producing an extract containing phytochemicals from pomegranates are disclosed. The processes generally comprise providing pomegranate solids, such as the pericarp, inner membrane and seeds; creating a mixture comprising the pomegranate solids in an aqueous solution; adding enzymes to the mixture in an amount sufficient to at least partially ... 11/23/06 - 20060263458 - Composition comprising growth factor of xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof This invention provides a process of producing extract comprises growth-stimulation components from husks, kernels, leaves, fruit-stems, branches, stems, roots, seed's shells and barks and their applications. A use of composition comprising the extract from the husks, kernels, leaves, fruit-stems, branches, stems, roots, seed's shells and barks of Wenguanguo for stimulating ... 11/09/06 - 20060251752 - Compositions for treating and/or preventing pollinosis The present invention provides a composition for treating and/or preventing pollinosis which comprises an extract from Sasa albo-marginata in an amount ranging from 1 to 10% by mass as expressed in terms of the solid content of the extract. The composition of the present invention comprises a Sasa albo-marginata extract ... 10/05/06 - 20060222724 - Reproductive cell system Compositions or extracts (2)(15)(24)(25)(16)(23)(31)(36)(41) obtained from the fruit (4) or leaves (26) of plants of the genus Hippophea (1) and methods of using such compositions or extracts to reduce loss of reproductive cell function. ... 10/05/06 - 20060222723 - Terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere A composition of terpene-based substances comprises a sesquiterpene fraction and/or a triterpene fraction derived from natural resins in which the fractions are intimately mixed with a gum component. The sesquiterpene and/or the triterpene fraction is present in the composition, separated from the gum component. ... 09/14/06 - 20060204600 - Dragon's blood anti-viral materials and methods The present invention provides for the administration of compounds, which can be synthesized or can be isolated from a Croton plant species for treating invertebrates or vertebrates, including humans, infected with Poxyiridae or Papillomavirinae. The present invention encompasses methods of using compounds synthesized or isolated from the Croton plant species, ... 08/31/06 - 20060193932 - Morinda citrifolia enhanced colon cancer cell growth inhibitor The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise ... 08/31/06 - 20060193931 - Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof The present invention provides a nutritional composition and a pharmaceutical composition to be used for humans or animals comprising as active compound the oleuropein compound or one derivative thereof. ... 08/24/06 - 20060188591 - Bauhinia extracts The present invention relates to an plant extract from Bauhinia species with hypoglycemic activity, which is characterized in being obtained from a Bauhinia species and to a method for producing the extract and the use of the extract in the treatment of diabetes type 2. ... 08/10/06 - 20060177530 - Method of treating diabetes type ii A method of treating early diabetic neuropathy includes administering a composition comprising an aqueous extract of olives is disclosed. A method of treating patients with Cfiber neuropathy includes administering a composition comprising an aqueous extract of olives. A method of treating patients with large fiber and C-fiber neuropathy includes administering ... 07/27/06 - 20060165824 - Compositions, kits, and methods for enhancing gastrointestinal health Disclosed herein are compositions, kits, and methods useful for enhancement of gastrointestinal health. For example, compositions comprising matter derived from a plant of the genus Terminalia; and a soluble fiber are disclosed. Also disclosed are kits wherein the extract of the plant matter and the soluble fiber need not be ... 07/20/06 - 20060159788 - Method and formulation for treating candidiasis using morinda citrifolia The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, ... 07/20/06 - 20060159787 - Product with insect-repellent and/or insecticidal activity and method of production thereof An insect-repellent and/or insecticidal product is described obtained by concentration of by-product vegetable water from olive milling, characterized in that it has a dry matter content of 10% or higher and a pH of 5 or higher; a method for the preparation of such a product is also described comprising ... 07/13/06 - 20060153940 - Use of physiologically active fatty acids Compositions comprising physiologically active fatty acids, salts and esters thereof are disclosed, and may be used in combination with extracts of Castanea sativa or active principles thereof for treating lipodystrophy by administering to a patient in need thereof. ... 07/13/06 - 20060153939 - Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use The invention relates to a method of obtaining a stable product of natural vegetable origin, particularly macadamia oil, which is treated in a reactor in which the oil is exposed to a continuous flow of ozone and, subsequently to a feedback of end gases under the influence of an electromagnetic ... 06/22/06 - 20060134245 - Estrogenic extracts of morus alba and uses thereof Extracts of various species of the Moraceae family have estrogenic properties. For example, aqueous and ethanolic extracts of Morus alba L. species possess estrogenic properties in both ERα+ and ERβ+ cells. These estrogenic effect include estrogen response element (ERE) stimulation as well as tumor necrosis factor (TNF) repression. Methods are ... 06/15/06 - 20060127510 - Harvesting and pelletizing yew biomass for extraction of taxanes and other natural products A process for harvesting yew biomass and a process of making Yew pellets from Yew tree material is disclosed herein. The process for harvesting comprising the steps of (i) harvesting the tops or roots of the Yew tree; (ii) washing the harvested material; (iii) drying the harvested material; and (iv) ... 06/08/06 - 20060121138 - Hepatocurative effect of emblica officinalis against cyp 450 bio-activation hepatotoxicity of drugs The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity. ... 05/18/06 - 20060105069 - Pharmaceutical and therapeutic compositions derived from garcinia mangostana l plant The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a ... 05/04/06 - 20060093688 - Nutritional olive oil based compositions, and method of consumption thereof A nutritional, olive-oil based, at least semi-solid product for oral intake and for topical application, the product including: (a) an olive oil; (b) an omega-3 fatty acid source, and (c) an emulsifier, the components being intimately mixed so as to form the at least semi-solid product, and wherein a Total ... 04/27/06 - 20060088616 - Compositions containing malva sylvestris extract and use thereof on mucosal tissues The present invention relates to a method of enhancing the mucus production of mucosal tissue by administering to mucosal tissue in need of such enhancement a composition containing a safe and effective amount of Malva sylvestris extract. ... 04/27/06 - 20060088615 - Compositions containing malva sylvestris extract and use thereof on skin and mucosal tissues The present invention relates to a method of enhancing the elasticity or structural integrity of skin or mucosal tissue by administering to skin or mucosal tissue in need of such enhancement a composition containing a safe and effective amount of Malva sylvestris extract. ... 04/20/06 - 20060083800 - Composition for the treatment of malaria A composition for use in treating malaria includes: 4%-38% fever nut by weight; 24%-89% kutaki by weight; 3%-28% five-leaved chaste tree by weight; and 3%-26% karchi by weight. ... 03/30/06 - 20060068044 - Antimicrobial compositions and applications therefore The present invention relates to a composition derived from an essential oil obtained from one or more plants of the Melaleuca family in which at least 80% of the monoterpene content of the oil has been removed. The present invention also relates to a number of applications of the composition ... 03/23/06 - 20060062866 - Tyrosinase inhibitor and method for preparation A complex comprising a starch and an active anti-HIV-1 or anti-HIV-2 ingredient of pomegranate juice that is adsorbed on the starch when the starch is in a water insoluble form. The complex inhibits HIV-1 or HIV-2 infection and blocks the binding of HIV-1 or HIV-2 to the CD4 receptor and ... 03/23/06 - 20060062865 - Tyrosinase inhibitor and method for preparation A Tyrosinase inhibitor extracted from Osage orange (Maclura pomifera) heartwood is described. Methods of producing the extract as well as a variety of applications for the extract are also described. Applications for the extract include use as a skin-whitening agent in cosmetic products, a pharmaceutical agent interfering with the aromatic ... 03/16/06 - 20060057235 - Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans Methods of using pomegranate extracts of the present invention for treating patients with atherosclerosis, or increased intima-media thickness of an artery, are provided. The methods comprise the step of administering to the patient a composition comprising a therapeutically effective amount of an extract from pomegranate. The methods of the present ... 01/26/06 - 20060018985 - Ant away “Ant Away” is made from a petri dish that contains three (3) grams of dried bay leaves. When placed in dwellings, the object of this product will be to deter ants from dwellings. The aroma from the dried bay leaves will permeate through the ⅛″ holes drilled on the lid ... 01/19/06 - 20060013905 - Anti-inflammatory compositions for treating multiple sclerosis Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biochemicals from the activated mast cells, the compositions containg one or more of a flavone or flavonoid glycoside a heavily sulfated, non-bovine proteoglycan, an unrefined olive kernel ... 12/29/05 - 20050287235 - Antiulcer herbal compositions The invention provides a novel herbal synergistic formulation for treatment of acute and chronic ulcers in stomach. Formulation(s) comprises of plant extracts together with the conventional additives to form the oral dosage forms which include tablets, capsules and powders ready for suspension. Utleria solicifolia along with this plants used traditionally ... 12/22/05 - 20050281902 - Compositions containing an active fraction isolated from lycium barbarum and methods of using the same The present invention provides extracts of Lycium barbarum useful for inhibiting, interfering and/or controlling pathological angiogenesis or neovascularization of tissues. The invention also provides a method to inhibit metastasis of cancer of colon, lung, liver, kidney, breast and/or cervix in a subject, comprising administering an effective amount of an extract ... 12/22/05 - 20050281901 - Composition to enhance hdl cholesterol and to decrease intima-media thickening in animals and humans and a method for its preparation A method of producing a product to correct hypercholesterolemia comprising pulping fruits of Emblica Officinalis with demineralized water to create a slurry. The slurry is treated with pectinase. The slurry is filtered to create a solution. The solution is concentrated to create a product. ... 11/24/05 - 20050260291 - Methods and compositions for reactivating acetylcholinesterase The present invention relates to methods and compositions for reactivating Acetylcholinesterase in living organisms using contents from the Morinda citrifolia L. plant. More particularly, the present invention relates to methods and compositions involving the reactivation of Acetylcholinesterase using fruit juice obtained from the Morinda citrifolia L. plant. ... 10/27/05 - 20050238740 - Use of mastic and its components for the control of microbial infections Pharmaceutical formulations and methods of manufacture of such formulations used in the treatment of microbial infections and cell proliferation conditions. The pharmaceutical formulations include anti-microbial and/or anti-cell proliferation agents which comprise a mastic extract product and essential oil, or a mastic isolated component, or synthetic equivalents thereof prepared as oral ... 10/20/05 - 20050233016 - Plant extracts The invention relates to a method for preparing an saponin-containing aqueous extract on the basis of a waste product from a butter tree of the Sapotaceae family, said method comprising the following steps: (i) mixing one part waste product with 4-30 parts of water; (ii) incubating the mixture formed in ... 10/20/05 - 20050233015 - Lanolin substitute based on shea butter The invention refers to a lipid composition with lanolin-like properties, which comprises a combination of non-polar unsaponifiable matter from vegetable oils and fats and a polar mixture of fatty acid esters. The composition can be used as a lanolin substrate in different formulations, especially for cosmetic use. ... 10/13/05 - 20050226950 - Process for isolation of withaferin-a from plant materials and products therefrom The present invention relates to an improved process of analytical and quantitative isolation of withaferin-A from Withania somnifera (Sanskrit: Ashwagandha, English: winter cherry) and other plants and products therefrom, said method comprising steps of selecting most appropriate extraction medium composition, with extraction solvent system consisting of a defined admixture of ... 10/06/05 - 20050220911 - Anti-allergic composition and method for denaturing allergen An anti-allergic composition comprising at least one plant or extract selected from the Oleaceae group consisting of Olea spp. and Ligustrum spp., and a hygroscopic material is effective for denaturing the allergens originated from house dusts, mites and pollen. ... 10/06/05 - 20050220910 - Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof This invention provides compositions, methods and process of producing extracts from Xanthoceras sorbifolia. The extract comprises alkaloids, coumarins, saccharides, proteins, polysaccharides, glycosides, saponins, tannins, acid, flavonoids and others. The composition can be used for treating cancer, arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, ... 10/06/05 - 20050220909 - Composition for protection against superficial vasodilator flush syndrome Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, an unrefined olive kernel oil/extract that increases ... 10/06/05 - 20050220908 - Anti-inflammatory compositions for multiple sclerosis Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, an unrefined olive kernel oillextract that increases ... 10/06/05 - 20050220907 - Implanted medical devices with anti-inflammatory coatings Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, an unrefined olive kernel oil/extract that increases ... 09/29/05 - 20050214394 - Hippophae rhamnoides compositions for cancer therapy Methods and compositions for prevention and therapy of cancer using a therapeutically effective amount of an extract of Hippophae rhamnoides (sea buckthorn) leaves, berries, and seeds are provided. Novel uses of these compositions in different stages of cancer therapy are disclosed. Novel compositions comprising Hippophae rhamnoides extracts that preferentially inhibit ... 09/22/05 - 20050208163 - Compositions containing avocado leaf extract for lowering cholesterol levels The present invention relates to compositions containing Persea american var. drymifolia leaf and leaf extracts for lowering cholesterol levels and methods thereof. ... 09/22/05 - 20050208162 - Esterified fatty acid composition The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions ... 09/15/05 - 20050202109 - Methods and compositions for inhibiting monoamine oxidase and catechol-o-methyltransferase The present invention relates to methods and compositions for inhibiting Monoamine Oxidase and/or Catechol-O-Methyltransferase in living organisms. More particularly, the present invention relates to methods and compositions involving the inhibition of Monoamine Oxidase and/or Catechol-O-Methyltransferase using processed Morinda citrifolia L. plant products. ... 09/15/05 - 20050202108 - Methods and compositions for inhibiting angiotensin converting and chymase enzymes The present invention relates to medicinal products, as well as to health and wellness food products, and particularly to a medicinal product or a health and wellness food product for inhibiting Angiotensin Converting Enzyme and Chymase enzyme pathways. ... 09/08/05 - 20050196478 - Methods using lycium barbarum extracts as neuroprotective agents for retinal ganglion cells degeneration An Lycium barbarun extract demonstrates a neuroprotective effect on damaged retinal ganglion cells, preventing and preserving retinal ganglion cells from degeneration in the treated subjects after chronic and traumatic neuronal injury or glaucoma. Compositions include an effective amount of an agent and a pharmaceutically acceptable vehicle. ... 09/08/05 - 20050196477 - Mangosteen protein supplement A nutraceutical protein supplement composition containing xanthones and proteins is disclosed. The protein supplement, preferably, contains xanthones derived from fruit of the Garcinia mangostana L. plant, otherwise known as the mangosteen plant, especially from the pericarp or the whole fruit of the mangosteen plant. ... 09/08/05 - 20050196476 - Morinda citrifolia leaf extract compositions and methods of obtaining the same Methods and compositions relating to leaf extracts obtained from removing liquids from relatively dry Morinda citrifolia leaves. Methods and compositions relating to a leaf serum created from combining leaf extract and fruit juice from the Morinda citrifolia L. plant. Methods and compositions relating to leaf extract compositions comprising one or ... 08/25/05 - 20050186296 - Profiles of lipid proteins and inhibiting hmg-coa reductase The present invention comprises methods and compositions for improving profiles of lipid proteins, reducing low-density lipoprotein levels, increasing high-density lipoprotein levels, decreasing the absorption of fatty acids across the intestinal epithelium and inhibiting HMG-CoA Reductase in living organisms utilizing Morinda citrifolia L activity in mammals, including humans. ... 08/18/05 - 20050181082 - Morinda citrifolla based antifungal formulations and methods The present invention provides a formulation which may be utilized in agricultural practice that is eco-friendly and effective as plant growth promotion agent, soil improvement agent, bactericide and insecticide agent, disease and harmful insect prevention agent, and is suitable for organic farming. The formulation of the present invention is comprised ... 08/04/05 - 20050170027 - Novel hepatic disorder suppressant A hepatic disorder suppressant comprising extracts having hepatic disorder suppressing effect as effective ingredients, wherein the extracts is obtained by extracting an avocado plant and/or a processed product thereof with an organic solvent is disclosed. ... 07/28/05 - 20050163877 - Novel hepatic disorder suppressant A hepatic disorder suppressant comprising extracts having hepatic disorder suppressing effect as effective ingredients, wherein the extracts is obtained by extracting an avocado plant and/or a processed product thereof with an organic solvent is disclosed. ... 07/28/05 - 20050163876 - Cancer treatment using natural plant products or essential oils or components from some pistacia species Natural products or pharmaceutical compositions containing plant essential oil, from P. terebinthus, P. lentiscts, P. vera, P. integerrima or other Pistacia species, or their components, natural or synthetic, or mixture or derivatives thereof, for the prevention and treatment of cancer. ... 07/28/05 - 20050163875 - Novel hepatic disorder suppressant A hepatic disorder suppressant comprising extracts having hepatic disorder suppressing effect as effective ingredients, wherein the extracts is obtained by extracting an avocado plant and/or a processed product thereof with an organic solvent is disclosed. ... 07/21/05 - 20050158412 - Type ii diabetes The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a nutraceutical composition or treatment formulated with one or more processed Morinda citrifolia products, including TAHITIAN NONI® juice and juice concentrate, as derived ... 07/14/05 - 20050153003 - Anti-aging cosmetic composition and method of application The present invention provides topical compositions and methods to prevent and/or ameliorate the effects of aging on skin and/or hair. The present invention also provides topical compositions and methods to improve the aesthetic appearance of skin, scalp and/or hair. The invention utilizes the topical application of crape myrtle extract to ... 07/07/05 - 20050147700 - Preventative and treatment effects of morinda citrifolia on diabetes and its related conditions The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda ... 06/30/05 - 20050142233 - Compositions for treating and/or preventing pollinosis The present invention provides a composition for treating and/or preventing pollinosis which comprises an extract from Sasa albo-marginata in an amount ranging from 1 to 10% by mass as expressed in terms of the solid content of the extract. The composition of the present invention comprises a Sasa albo-marginata extract ... 06/09/05 - 20050123634 - Method for modulating steroidogenic activity The present invention relates generally to a method for modulating steroidogenic activity and a composition useful for same. The present invention further relates to a composition comprising a steroidogenic modulator useful for modulating physiological processes mediated by the androgen receptor or an active form thereof or complex comprising same and/or ... 06/02/05 - 20050118291 - Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane The present invention advances prior art techniques, formulations, and methods for treating mammary breast cancer during its initial phases, as well as for preventing mammary breast cancer, by providing a safe, nutraceutical formulation comprising Morinda citrifolia, methylsulfonylmethane (MSM), and other ingredients. ... ### FreshPatents.com Support |